Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-788-8 | CAS number: -
Endpoint summary
Administrative data
Description of key information
LD50 (oral, rat) > 5000 mg/kg b.w
LD50 (dermal, rat) > 5000 mg/kg b.w
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Additional information
ACUTE ORAL TOXICITY
The oral acute toxicity study was performed according to an internal method: a group of male white rats was treated with a single dose of 5000 mg/kg b.w. test substance, diluted with DMSO and administered by oral intubation.
The acute oral LD50 of the substance in rats was found to be more than 5000 mg/kg b.w..
ACUTE DERMAL TOXICITY
The dermal acute toxicity study was performed according to an internal method: a group of male white rats was treated with a single dose of 5000 mg/kg b.w. by dermal route. Gauze pads with the test substance were applied for 4 hours on the skin of the back of animals and the treated skin areas were not washed after the exposure.
The acute dermal LD50 of the substance in rats was found to be more than 5000 mg/kg b.w.
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
In the case of oral exposure route, the acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories are:
-Category 1: ATE ≤ 5 mg/kg bw
-Category 2: 5 < ATE ≤ 50 mg/kg bw
-Category 3: 50 < ATE ≤ 300 mg/kg bw
-Category 4: 300 < ATE ≤ 2000 mg/kg bw
In the case of dermal exposure route, the acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories are:
-Category 1: ATE ≤ 50 mg/kg bw
-Category 2: 50 < ATE ≤ 200 mg/kg bw
-Category 3: 200 < ATE ≤ 1000 mg/kg bw
-Category 4: 1000 < ATE ≤ 2000 mg/kg bw
The acute oral and dermal LD50 in rats were found to exceed 5000 mg/kg bw in both cases.
Therefore, the substance is not classified for oral and dermal acute toxicity according to the CLP Regulation (EC n. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
